#DEFCON is coming to #singapore !

DEF CON and HTX will be co-organizing DEF CON SG, with CTIS as our strategic partner.

Join us at the Marina Bay Sands April 28-30, 2026 for the full DEF CON experience: presentations, hands-on Villages, contests and musical entertainment.

Bonus: 2-day DEF CON Training courses to level up your technical skills April 26-27.

Follow all the updates on the web at https://defcon.org/html/defcon-singapore/dc-singapore-index.html and contact us @defcon on defcon.social.
See you there!

#defconsingapore #htx #ctis #savethedate

#clinicaltrials: ctrdata analysis tool #R package v1.12.1 now supports #CTIS, the recently launched EU Clinical Trials Information System, with first set of protocol- & application-related information - in addition to CTGOV, EUCTR and ISRCTN. Feedback welcome! #rstats https://cran.r-project.org/package=ctrdata
ctrdata: Retrieve and Analyze Clinical Trials in Public Registers

A system for querying, retrieving and analyzing protocol- and results-related information on clinical trials from three public registers, the 'European Union Clinical Trials Register' ('EUCTR', <<a href="https://www.clinicaltrialsregister.eu/">https://www.clinicaltrialsregister.eu/</a>>), 'ClinicalTrials.gov' ('CTGOV', <<a href="https://clinicaltrials.gov/">https://clinicaltrials.gov/</a>>), the 'ISRCTN' (<<a href="http://www.isrctn.com/">http://www.isrctn.com/</a>>) and the 'European Union Clinical Trials Information System' ('CTIS', <<a href="https://euclinicaltrials.eu/">https://euclinicaltrials.eu/</a>>). Trial information is downloaded, converted and stored in a database ('PostgreSQL', 'SQLite', 'DuckDB' or 'MongoDB'; via package 'nodbi'). Functions are included to identify deduplicated records, to easily find and extract variables (fields) of interest even from complex nesting as used by the registers, and to update previous queries. The package can be used for meta-analysis and trend-analysis of the design and conduct as well as for results of clinical trials.

📢 The highlights of the Management Board meeting are now available.

Read more about
➡️the Agency’s additional responsibilities as part of its extended mandate
➡️the recent operational experience with the #clinicaltrials information system (#CTIS).

👉https://www.ema.europa.eu/en/news/ema-management-board-highlights-march-2023-meeting

🐦🔗: https://n.respublicae.eu/EMA_News/status/1636750775446536194

EMA Management Board: highlights of March 2023 meeting - European Medicines Agency

EMA Management Board: highlights of March 2023 meeting

European Medicines Agency

@evawolfangel @renereh1
Die Denk- und Arbeitskultur an den meisten Unis ist glücklicherweise libertär und dezentral by nature. Als Forschender in der Informatik können mir die Admins manchmal aber leid tun, wenn sie es mit sehr individuellen technischen Setups und Infrastrukturwünschen durch mich und meine Kollegen zu tun bekommen… lokale Pauschallösungen gibt es nicht, wie Thomas Grünewald richtigerweise erklärt hat.

Richtig und notwendig wäre hier, wie es bereits in der Wirtschaft langsam einsickert, ein Umdenken auf Kooperation und Allianzbildung anstelle von Geheimhalterei und security by obscurity. Ironischerweise könnten gerade dabei dezentrale Infrastrukturen helfen, etwa ein gut ausgebautes und gepflegtes Threat Intelligence Netzwerk für den öffentlichen Bereich.

#infosec #cybersecurity #tis #cti #ctis #threadintelligence #informationsharing

📢 From today, all initial clinical trial applications in the EU 🇪🇺 must be submitted via #CTIS!

All clinical trial sponsors will now use the same system and follow the same procedures to apply for the authorisation of a #clinicaltrial.

➡️ https://www.ema.europa.eu/en/news/use-clinical-trials-information-system-becomes-mandatory-new-clinical-trial-applications-eu

🐦🔗: https://n.respublicae.eu/EMA_News/status/1620367835217428481

Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU - European Medicines Agency

Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU

European Medicines Agency

On 18 January, EMA’s Management Board was provided with an update on recent improvements introduced in the Clinical Trials Information System (#CTIS) and progress made for its mandatory use from 31 January 2023.⏰🗓️

➡️https://www.ema.europa.eu/en/news/mandatory-use-ctis-31-january-2023-all-new-clinical-trial-applications

#EUClinicalTrials

🐦🔗: https://n.respublicae.eu/EMA_News/status/1616085679544344576

Mandatory use of CTIS from 31 January 2023 for all new clinical trial applications - European Medicines Agency

Mandatory use of CTIS from 31 January 2023 for all new clinical trial applications

European Medicines Agency

Heute im #Background: #DKG plant Auswirkungsanalyse | Ein IT-Flop namens #CTIS | #KBV-Vorstand auf Distanz zu #HNO-Verbänden | Im #Standpunkt: Thomas Gambke Vorsitzender des Grünen Wirtschaftsdialogs und Dennis A. Ostwald CEO und Gründer des WifOR Institute

Hier anmelden und lesen 👉 https://background.tagesspiegel.de/gesundheit

Gesundheit & E-Health - Tagesspiegel Background

Gesundheit & E-Health: Das tägliche Entscheiderwissen. Für Politik, Wirtschaft, Wissenschaft, Verbände und NGO. Vom Tagesspiegel, der Nr. 1 aus der Hauptstadt.

At its October meeting, our Management Board heard updates on topics including our extended mandate, our working parties and the Clinical Trials Information System. #CTIS
👉https://www.ema.europa.eu/en/news/ema-management-board-highlights-october-2022-meeting

🐦🔗: https://nitter.eu/EMA_News/status/1578405634139095047

EMA Management Board: highlights of October 2022 meeting - European Medicines Agency

EMA Management Board: highlights of October 2022 meeting

European Medicines Agency
#Transmissão continua bastante alta. Não temos + a pesquisa #CTIS p/monitorar pessoas c/sintomas (acabou em 25/06/22) e a #Testagem reduziu MUITO:
Quantidade de testes registrada em ambiente laboratorial em 21/06/22 -
pic.twitter.com/FuefEVUTsh -
RT Isaac Schrarstzhaupt -
Isaac Schrarstzhaupt on Twitter

“Transmissão continua bastante alta. Agora não temos mais a pesquisa CTIS para monitorar pessoas com sintomas (acabou em 25/06/22) e a testagem reduziu MUITO. Vejam a quantidade de testes registrada no gerenciador de ambiente laboratorial (atualizado em 21/06/22):”

Twitter

RT @bfarm_de: BfArM President @Karl_Broich: Our aim is to improve the way #EUclinicaltrials are regulated to better support medical research + innovation. #CTIS is an important step to simplify and expedit the application process. But we want to go further: https://t.co/0p5wgHe2VR #ICTD2022

🐦🔗: https://nitter.eu/EMA_News/status/1527575848638984192

BfArM - Blog - "Working towards a fundamental transformation of the clinical research environment"

Clinical trials are a prerequisite for medical progress. They offer patients a chance at early access to innovative therapeutic options as new treatment possibilities are introduced into medical practice. Prof. Karl Broich, President of the BfArM explains why Europe is such an important environment for clinical trials and what changes are necessary with regard to authorisation procedures.